In the present study, we tried to determine if coenzyme Q10 and the skeletal muscle protein biomarkers such as albumin, creatine kinase, irisin, and myostatin, could be used to assist in the diagnosis of sarcopenia. This evidence concerns the gene FNDC5 and sarcopenia.